Indication
Azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension; open-angle glaucomaas monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- AzoptBrazil · Novartis Biociencias S.ASame brand
- AzoptBrazil · Alcon Laboratórios do Brasil Ltda.Same brand
- AzoptCanada · 1 % / W/V · Suspension · Novartis Pharmaceuticals Canada INCSame brand
- AZOPT 10 mg/ml COLIRIO EN SUSPENSIONSpain · 10 mg · colirio en suspensión · Novartis Europharm LimitedSame brand